LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 7 of 166
Next
>>
>
151 to 175 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	CP724714	0.12	uM	LJP5	72	hr	1657	5078	5505	0.9224	0.8889
BT-20	CP466722	0.12	uM	LJP5	72	hr	1657	5575	5505	1.0127	1.0182
BT-20	Crizotinib	0.12	uM	LJP5	72	hr	1657	5034	5505	0.9143	0.8774
BT-20	Momelotinib	0.12	uM	LJP5	72	hr	1657	4769	5505	0.8663	0.8086
BT-20	Dasatinib	0.12	uM	LJP5	72	hr	1657	3500	5505	0.6358	0.4789
BT-20	Dasatinib	0.12	uM	LJP6	72	hr	1657	1833	5505	0.3331	0.0457
BT-20	Dovitinib	0.12	uM	LJP5	72	hr	1657	4026	5505	0.7313	0.6155
BT-20	Enzastaurin	0.12	uM	LJP5	72	hr	1657	5937	5505	1.0785	1.1123
BT-20	Erlotinib	0.12	uM	LJP5	72	hr	1657	5003	5505	0.9087	0.8694
BT-20	Foretinib	0.12	uM	LJP5	72	hr	1657	4719	5505	0.8571	0.7956
BT-20	R406	0.12	uM	LJP6	72	hr	1657	5542	5505	1.0067	1.0095
BT-20	Pictilisib	0.12	uM	LJP6	72	hr	1657	4346	5505	0.7894	0.6986
BT-20	Gefitinib	0.12	uM	LJP6	72	hr	1657	5388	5505	0.9788	0.9696
BT-20	Geldanamycin	0.12	uM	LJP5	72	hr	1657	1971	5505	0.3580	0.0814
BT-20	Geldanamycin	0.12	uM	LJP6	72	hr	1657	1888	5505	0.3430	0.0599
BT-20	GSK1059615	0.12	uM	LJP5	72	hr	1657	4269	5505	0.7755	0.6788
BT-20	GSK1059615	0.12	uM	LJP6	72	hr	1657	2789	5505	0.5066	0.2941
BT-20	GSK1904529A	0.12	uM	LJP6	72	hr	1657	4877	5505	0.8858	0.8366
BT-20	Omipalisib	0.12	uM	LJP6	72	hr	1657	1438	5505	0.2612	-0.0571
BT-20	GSK 690693	0.12	uM	LJP5	72	hr	1657	4599	5505	0.8353	0.7644
BT-20	GW843682X	0.12	uM	LJP6	72	hr	1657	3476	5505	0.6314	0.4726
BT-20	HG-5-113-01	0.12	uM	LJP5	72	hr	1657	5005	5505	0.9092	0.8701
BT-20	HG-5-88-01	0.12	uM	LJP6	72	hr	1657	5270	5505	0.9573	0.9388
BT-20	Imatinib	0.12	uM	LJP6	72	hr	1657	5758	5505	1.0460	1.0657
BT-20	JNK-9L	0.12	uM	LJP6	72	hr	1657	4144	5505	0.7527	0.6462

|<
<<
Previous
Page 7 of 166
Next
>>
>
151 to 175 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)